UnitedHealth Stocks Slip Although Profit Outlook Rises Again

UnitedHealth reported a 75% profit increase to $4.1B in Q3, exceeding forecasts, but revenue fell 2.2% to $87.1B. The company reduced medical costs by $3B and covered 2.5M fewer people. Stock initially rose 4% but later fell due to investor concerns about future growth and reliance on reserve releases. UnitedHealth raised its annual earnings forecast to at least $20.50 per share.

UnitedHealth Group (NYSE:UNH) expects its Medicaid margins to improve after 2026, with 2026 projected at slightly better than -1%. The company and others received high ratings from CMS for Medicare Advantage plans. UnitedHealth and CVS's Aetna plan to tighten networks by 2027 due to rising costs. UnitedHealth also introduced 2027 Medicare Advantage plans with $0 premiums.

UnitedHealth reported Q3 revenue of $112.7B, down slightly YoY, but earnings from operations rose to $6.6B. CEO Steve Hemsley highlighted AI's role in reducing chart review time by 33% for clinicians and appeal cycle times by 26%. The company is also introducing AI-powered plan recommendations for Medicare Advantage. Optum Health saw a 27% YoY surge in online self-scheduling and a 10% increase in home health visits.

UnitedHealth Group reported Q3 2026 revenue of $112.7B and operating earnings of $6.6B, raising its full-year earnings outlook to at least $19.50 per share. The company cited improved profitability across UnitedHealthcare and Optum, with better medical cost management and operating efficiencies. UnitedHealthcare served 48.3M people, while Optum generated $66.9B in revenue and $3.73B in operating earnings.

UnitedHealth Group (UNH) reported Q3 2026 revenue of $113 billion and adjusted EPS of $4.69, up from $2.92 a year ago. The company raised its full-year adjusted EPS guidance to at least $20.50. Key highlights include a 30% reduction in prior authorizations, AI-driven efficiencies, and Medicare Advantage margin expectations near the top of the 2% to 4% range. Challenges include elevated commercial medical trends and negative Medicaid margins.

UnitedHealth Group (UNH) reported Q3 2026 revenue of $113B and adjusted EPS of $4.69, reaffirming its full-year EPS guidance of at least $20.50. The company offers a 2.41% dividend yield with a 58% payout ratio and a 10.9% 3-year dividend growth rate. UNH's GF Score is 81/100, indicating strong fundamentals, particularly in profitability and momentum. Insider activity shows net selling, while 35 premium gurus hold the stock, with mixed sentiment among institutional investors.